ProCGlobal and endogenous thrombin potential during pregnancy

Am J Obstet Gynecol. 2010 Nov;203(5):463.e1-6. doi: 10.1016/j.ajog.2010.05.034. Epub 2010 Jul 3.

Abstract

Objective: Pregnancy is a hypercoagulable state. We evaluated global markers of coagulation activation, ProCGlobal (Siemens Healthcare Diagnostics, Eschborn, Germany) and endogenous thrombin potential (ETP), in pregnant women with and without low-molecular-weight (LMW) heparin prophylaxis.

Study design: We prospectively followed 113 healthy women and 61 women receiving LMW heparin prophylaxis throughout pregnancy. ProCGlobal and ETP were measured in venous blood during the first, second, and third trimester.

Results: ProCGlobal decreased significantly throughout pregnancy in all women and was lower in anticoagulated women (P < .001 for all comparisons). ETP levels remained unchanged until the third trimester and then significantly decreased in all women. ETP was higher in anticoagulated women than in healthy women at all time points.

Conclusion: ProCGlobal levels decrease throughout pregnancy. In pregnant women at high thrombotic risk, coagulation activation reflected by low ProCGlobal and high ETP levels is substantial despite LMW heparin prophylaxis.

MeSH terms

  • Adult
  • Analysis of Variance
  • Anticoagulants / therapeutic use
  • Blood Coagulation / drug effects*
  • Female
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Pregnancy
  • Pregnancy Complications, Hematologic / blood*
  • Pregnancy Complications, Hematologic / drug therapy
  • Prospective Studies
  • Protein C / analysis
  • Protein C / metabolism*
  • Thrombin / analysis
  • Thrombin / metabolism*
  • Thrombophilia / blood*
  • Thrombophilia / drug therapy

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Protein C
  • Thrombin